SmartDx
SmartDx offers direct-to-consumer canine genetic testing to assess risk for cardiac and cancer-related diseases. SmartDx uses proprietary bioinformatics and machine learning to process sequencing data from a mouth swab and convert it into a binary format, enabling accurate disease risk predictions. It operates as a direct-to-consumer veterinary product with the potential for use by pet owners, breeders, or veterinarians, placing it in the veterinary genetic testing space. The service falls under B2C with notable B2B elements, incorporating communication with veterinary professionals and breeders. The platform targets the growing pet health market by enabling early, personalized preventive care at scale.
SmartDx
SmartDx offers direct-to-consumer canine genetic testing to assess risk for cardiac and cancer-related diseases. SmartDx uses proprietary bioinformatics and machine learning to process sequencing data from a mouth swab and convert it into a binary format, enabling accurate disease risk predictions. It operates as a direct-to-consumer veterinary product with the potential for use by pet owners, breeders, or veterinarians, placing it in the veterinary genetic testing space. The service falls under B2C with notable B2B elements, incorporating communication with veterinary professionals and breeders. The platform targets the growing pet health market by enabling early, personalized preventive care at scale.